Today, crystallization is used primarily to analyze the structures of proteins. It also is gaining favor as a purification method for elastase, proteases, albumin, and lipase, in addition to ...
Over the years, bioprocessors could, at various times, debate whether upstream or downstream operations represented the slow step, relatively speaking, of therapeutic protein production. Now, with ...
The cell and gene therapy industry will greatly benefit from access to robust, scalable, end-to-end solutions for the production and characterization of native and engineered exosome therapeutics.” — ...
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...
Elemental impurity risk management can help biomanufacturers to maintain regulatory alignment and ensure patient safety.
LEXINGTON, Ky. (Nov. 17, 2022) - Dibakar "DB" Bhattacharyya, professor in the University of Kentucky Department of Chemical and Materials Engineering and Director of the Center of Membrane Sciences, ...
Nucleic acid purification is a common technique employed by numerous labs, including academic, pharmaceutical, agricultural, and many more. The combined costs of disposable reagents and the associated ...
UPPSALA, Sweden--(BUSINESS WIRE)--Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents, and a pioneer in automated nanoliter-scale immunoassays, today announced the ...
Continuous bioprocessing has emerged as a transformative approach in modern biomanufacturing, where integrated upstream and downstream operations enable uninterrupted production of biotherapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback